These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23235665)

  • 21. Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.
    Ageno W; Turpie AG; Steidl L; Ambrosini F; Cattaneo R; Codari RL; Nardo B; Venco A
    Am J Cardiol; 2001 Jul; 88(1):40-4. PubMed ID: 11423056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Kahale L; Terrenato I; Neumann I; Yosuico VE; Barba M; Sperati F; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006466. PubMed ID: 24980743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Kahale L; Terrenato I; Neumann I; Yosuico VE; Barba M; Sperati F; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD006466. PubMed ID: 24897382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Vasireddi SR; Gunukula S; Yosuico VE; Barba M; Terrenato I; Sperati F; Schünemann H
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006466. PubMed ID: 21678357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin.
    Kangelaris KN; Bent S; Nussbaum RL; Garcia DA; Tice JA
    J Gen Intern Med; 2009 May; 24(5):656-64. PubMed ID: 19306050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Vasireddi SR; Gunukula S; Yosuico VE; Barba M; Terrenato I; Sperati F; Schünemann H
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006466. PubMed ID: 21154368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials.
    Wang X; Tang B; Zhou M; Liu L; Feng X; Wang X; Qiu K
    Thromb Res; 2022 Feb; 210():42-52. PubMed ID: 34999431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral anticoagulation for prolonging survival in patients with cancer.
    Akl EA; Kamath G; Kim SY; Yosuico V; Barba M; Terrenato I; Sperati F; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD006466. PubMed ID: 17443622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.
    Tang T; Liu J; Zuo K; Cheng J; Chen L; Lu C; Han S; Xu J; Jia Z; Ye M; Pei E; Zhang X; Li M
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):387-94. PubMed ID: 25575537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio.
    Banet GA; Waterman AD; Milligan PE; Gatchel SK; Gage BF
    Chest; 2003 Feb; 123(2):499-503. PubMed ID: 12576372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
    Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
    Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
    Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of warfarin initiation regimens in elderly inpatients.
    O'Connell MB; Kowal PR; Allivato CJ; Repka TL
    Pharmacotherapy; 2000 Aug; 20(8):923-30. PubMed ID: 10939553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(12):1-114. PubMed ID: 23074516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
    Schulman S; Parpia S; Stewart C; Rudd-Scott L; Julian JA; Levine M
    Ann Intern Med; 2011 Nov; 155(10):653-9, W201-3. PubMed ID: 22084331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Bayesian dose-individualization method for warfarin.
    Wright DF; Duffull SB
    Clin Pharmacokinet; 2013 Jan; 52(1):59-68. PubMed ID: 23329393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial comparing 5-mg and 10-mg warfarin loading doses.
    Crowther MA; Ginsberg JB; Kearon C; Harrison L; Johnson J; Massicotte MP; Hirsh J
    Arch Intern Med; 1999 Jan; 159(1):46-8. PubMed ID: 9892329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetaminophen and other risk factors for excessive warfarin anticoagulation.
    Hylek EM; Heiman H; Skates SJ; Sheehan MA; Singer DE
    JAMA; 1998 Mar; 279(9):657-62. PubMed ID: 9496982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.